Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV CTL escape: at what cost?

Stephen M Smith1

  • 1Saint Michael's Medical Center and The New Jersey Medical School, Newark, New Jersey 07102, USA. ssmith1824@aol.com

Retrovirology
|June 1, 2004
PubMed
Summary

Human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) escape cytotoxic T lymphocytes (CTL) via mutations. These escape mutations reduce viral fitness, a crucial factor for developing effective CTL-based vaccines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain Connectivity Modelling Through Joint Estimation of Parcels and Gradients.

bioRxiv : the preprint server for biology·2026
Same author

Stable individual differences dominate adult brain volume variation until later life.

Imaging neuroscience (Cambridge, Mass.)·2026
Same author

The methodological foundations of lesion network mapping remain sound.

bioRxiv : the preprint server for biology·2026
Same author

Author Correction: UK Biobank at 20 - a growing, global resource for dementia research.

Nature reviews. Neurology·2026
Same author

UK Biobank at 20 - a growing, global resource for dementia research.

Nature reviews. Neurology·2026
Same author

Disease Site-Specific Outcomes in p16-Positive Non-Oropharyngeal Mucosal Head and Neck Cancer.

Head & neck·2026

Area of Science:

  • Immunology
  • Virology
  • Vaccinology

Background:

  • Cytotoxic T lymphocytes (CTL) are crucial for controlling HIV-1 and SIV infections.
  • Viruses like HIV-1 and SIV can evade CTL responses through mutations in viral epitopes.
  • Understanding viral escape mechanisms is key to designing effective vaccines.

Purpose of the Study:

  • To investigate the impact of viral escape mutations on HIV-1 and SIV fitness.
  • To explore the implications of CTL escape for the development of CTL-based vaccines.
  • To determine the conditions under which CTL-based vaccines can provide long-term protection.

Main Methods:

  • Analysis of recent data on HIV-1 and SIV epitope mutations.
  • Evaluation of studies demonstrating the fitness cost associated with viral escape.
  • Assessment of the relationship between viral fitness and vaccine efficacy.

Main Results:

  • HIV-1 and SIV escape from CTL responses is primarily mediated by epitope mutations.
  • These escape mutations impose a significant fitness cost on the virus.
  • Reduced viral fitness is linked to the effectiveness of CTL-based vaccines.

Conclusions:

  • Viral escape from CTLs through mutation comes at a cost to viral fitness.
  • Developing effective CTL-based vaccines requires understanding these escape mechanisms and their fitness implications.
  • Long-term protection from CTL-based HIV-1 vaccines depends on the weakened fitness of the escape virus.

Related Experiment Videos